🇺🇸 FDA
Pipeline program

GHB01L1

GHB-CS01

Phase 1 mab completed

Quick answer

GHB01L1 for Seasonal Human Influenza is a Phase 1 program (mab) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Atea Pharmaceuticals
Indication
Seasonal Human Influenza
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials